Services
We work with corporate leaders to identify
and develop strategies most likely to lead to business success.
We augment our strategy work with analytic tools that use
robust, credible methodologies and processes to help evaluate
drug assets and portfolios. Our analyses highlight the risk
and return of specific asset strategies and help pinpoint
gaps in the pipeline in time to take action. Management can
thoroughly evaluate alternatives and confidently communicate
to shareholders how a chosen course of action will generate
business value and achieve challenging goals.
Our strategic expertise encompasses:
- Business vision and corporate strategy
- Therapeutic area strategy
- R&D portfolio strategy
- Drug development strategy
- Commercialization strategy
- Licensing and mergers & acquisitions
strategy
|